BONAVITA, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 103
AS - Asia 99
EU - Europa 47
SA - Sud America 31
AF - Africa 3
Totale 283
Nazione #
US - Stati Uniti d'America 102
SG - Singapore 38
BR - Brasile 25
VN - Vietnam 21
CN - Cina 20
DE - Germania 15
IT - Italia 10
IN - India 9
FI - Finlandia 8
SE - Svezia 7
EC - Ecuador 3
GB - Regno Unito 3
CZ - Repubblica Ceca 2
HK - Hong Kong 2
TH - Thailandia 2
ZA - Sudafrica 2
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CA - Canada 1
CO - Colombia 1
ES - Italia 1
IQ - Iraq 1
JO - Giordania 1
KR - Corea 1
MA - Marocco 1
MY - Malesia 1
PY - Paraguay 1
SA - Arabia Saudita 1
UA - Ucraina 1
Totale 283
Città #
Singapore 19
San Jose 16
Munich 14
Ashburn 10
Turku 8
Ho Chi Minh City 7
Dallas 6
Bengaluru 5
Chandler 5
Hefei 5
Lawrence 5
Princeton 5
Santa Clara 5
Milan 4
Xian 4
Beijing 3
London 3
Wilmington 3
Augusta 2
Bangkok 2
Biên Hòa 2
Brasília 2
Chicago 2
Des Moines 2
Hanoi 2
Hong Kong 2
Olomouc 2
Quito 2
Amman 1
Angra dos Reis 1
Barretos 1
Basīrhat 1
Bình An 1
Cao Lanh 1
Cape Town 1
Carmópolis de Minas 1
Casablanca 1
Clearwater 1
Colorado 1
Columbus 1
Criciúma 1
Curitiba 1
Da Nang 1
Erbil 1
Exu 1
Fremont 1
Grand Rapids 1
Greensboro 1
Ha Long 1
Hanover 1
Itapemirim 1
Jaboatão dos Guararapes 1
Jeddah 1
Johannesburg 1
Juiz de Fora 1
Juneau 1
Kuala Selangor 1
Leawood 1
Long An 1
Luque 1
Maceió 1
Medellín 1
Mississauga 1
New York 1
Nova Friburgo 1
Orem 1
Pamplona 1
Parobé 1
Phú Thọ 1
Posadas 1
Redwood City 1
Rio de Janeiro 1
Salto 1
Salvador 1
San Francisco 1
Secaucus 1
Seoul 1
Shanghai 1
Sigsig 1
Sorriso 1
Surat 1
São José da Bela Vista 1
São João de Meriti 1
São Paulo 1
São Sebastião 1
Taboão da Serra 1
The Dalles 1
Thái Nguyên 1
Tây Ninh 1
Uberlândia 1
Yevlakh 1
Yên Bái 1
Totale 211
Nome #
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 75
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: A 18-month multicentre study 66
Genetic association of α2-macroglobulin polymorphisms with AD in southern Italy 55
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 53
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study 42
Totale 291
Categoria #
all - tutte 2.447
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.447


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 4 0 0
2021/202217 0 0 0 5 2 0 1 4 0 3 2 0
2022/202322 10 0 3 1 2 1 0 1 1 1 2 0
2023/202420 4 4 4 1 1 4 0 0 0 0 1 1
2024/202559 9 1 1 0 5 7 1 0 6 2 12 15
2025/2026151 13 17 26 33 18 7 9 4 21 3 0 0
Totale 291